Charles Schwab’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-22,423
| Closed | -$150K | – | 3209 |
|
|
2019
Q2 | $150K | Sell |
22,423
-12,667
| -36% | -$84.7K | ﹤0.01% | 3106 |
|
|
2019
Q1 | $125K | Buy |
35,090
+740
| +2% | +$2.64K | ﹤0.01% | 3077 |
|
|
2018
Q4 | $137K | Sell |
34,350
-3,092
| -8% | -$12.3K | ﹤0.01% | 3064 |
|
|
2018
Q3 | $740K | Buy |
37,442
+2,371
| +7% | +$46.9K | ﹤0.01% | 2708 |
|
|
2018
Q2 | $1.11M | Buy |
35,071
+20,137
| +135% | +$640K | ﹤0.01% | 2558 |
|
|
2018
Q1 | $553K | Buy |
14,934
+5,410
| +57% | +$200K | ﹤0.01% | 2705 |
|
|
2017
Q4 | $753K | Buy |
+9,524
| New | +$753K | ﹤0.01% | 2608 |
|